BRK-B vs MNSB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
MNSB presents a classic value trap profile with a stable Piotroski F-Score of 4/9 and a Graham Number of $32.32 suggesting significant defensive undervaluation. While the stock trades at a discount to book value (P/B 0.88) and shows strong top-line revenue growth of 31.8%, this is offset by a dismal earnings track record with zero beats in the last four quarters. The stark divergence between the Graham Number ($32.32) and the growth-based Intrinsic Value ($12.32) indicates that while assets are undervalued, the earning power is weak. Technical trends are heavily bearish (10/100), suggesting the market is pricing in these fundamental earnings struggles.
Compare Another Pair
Related Comparisons
BRK-B vs MNSB: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and MainStreet Bancshares, Inc. (MNSB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.